VeriMom¿Es eriodictyol seguro durante el embarazo?
No harmonised CLP classification or SCCS/CIR safety assessment for eriodictyol was identified (ECHA Annex VI/CIR). Peer‑reviewed literature reports biological activity of the flavanone class and some in vitro estrogenic/ER‑modulating activity for flavonoids (PubMed), so a theoretical mechanism (weak endocrine activity) is possible, but there are no in vivo reproductive toxicity or human teratogenicity data specifically for eriodictyol (PubMed, PubChem). Topical systemic absorption is plausible but expected low for typical cosmetic use given the compound’s flavanone structure and polarity (PubChem).
Related ingredients
Frequently asked questions
- ¿Es eriodictyol seguro durante el embarazo?
- No harmonised CLP classification or SCCS/CIR safety assessment for eriodictyol was identified (ECHA Annex VI/CIR). Peer‑reviewed literature reports biological activity of the flavanone class and some in vitro estrogenic/ER‑modulating activity for flavonoids (PubMed), so a theoretical mechanism (weak endocrine activity) is possible, but there are no in vivo reproductive toxicity or human teratogenicity data specifically for eriodictyol (PubMed, PubChem). Topical systemic absorption is plausible but expected low for typical cosmetic use given the compound’s flavanone structure and polarity (PubChem).
- ¿Es eriodictyol seguro durante la lactancia?
- No evidence of reproductive or lactation hazards, no harmonised classification or CIR/SCCS opinion (ECHA Annex VI; CIR). Theoretical endocrine activity based on class/limited in vitro data supports a low mechanistic concern only (PubMed). Systemic exposure after topical application is expected low but measurable, so breastmilk exposure would be low (PubChem; no specific human PK data found).
- ¿Es eriodictyol seguro para la piel del bebé?
- No infant‑specific toxicity data or harmonised flags (ECHA Annex VI/CIR). Mechanistic concern remains theoretical only (flavonoid class in vitro activity) with no in vivo reproductive/developmental data for eriodictyol (PubMed). Dermal exposure concern is elevated for 0–3 yr due to higher skin permeability and surface‑area‑to‑weight ratio; if adult topical exposure is low but measurable (e=1), infant exposure is increased by +1 per guidance (PubChem, PubMed).
- ¿Cómo puntúa VeriMom a eriodictyol?
- VeriMom puntúa eriodictyol en 87/100 (riesgo bajo) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a eriodictyol en el embarazo?
- Consulta nuestra lista de alternativas seguras a eriodictyol según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.